Recent Annual Reports

Browse the latest SEC filings with AI-powered analysis. Get insights into corporate performance, financial trends, and business developments.

📊 5202 Reports

🤖 AI Analyzed

Recent

📄 Page 61 of 434

Allarity Therapeutics, Inc.

10-K March 30, 2026

Key Highlights

Proprietary DRP® technology improves clinical trial success by identifying patie...
Strategic pivot to focus 100% of research budget on lead candidate stenoparib.
Stenoparib currently in Phase 2 trials for advanced ovarian cancer with early po...

Read Analysis

🤖 AI Generated

VanEck Ethereum ETF

10-K March 30, 2026

Key Highlights

Provides easy, regulated access to Ethereum via standard brokerage accounts.
Eliminates technical complexities like managing private keys or digital wallets.
Utilizes professional cold storage custody via Gemini and Coinbase for security.

Read Analysis

🤖 AI Generated

Eikon Therapeutics, Inc.

10-K March 30, 2026

Key Highlights

Led by CEO Roger Perlmutter, former head of R&D at Merck.
Proprietary 'Eikon Platform' utilizes super-resolution microscopy for drug disco...
Lead candidate EIK1001 is currently in Phase 2/3 global clinical trials.

Read Analysis

🤖 AI Generated

ECARX Holdings Inc.

20-F March 30, 2026

Key Highlights

Achieved $645.2 million in revenue, representing a 30% year-over-year growth.
Deep integration within the Geely ecosystem, powering over 5.6 million vehicles ...
Strategic shift from hardware-centric sales to high-margin software subscription...

Read Analysis

🤖 AI Generated

CLECO POWER LLC

10-K March 30, 2026

Key Highlights

Stable investment-grade credit rating supported by specialized securitization st...
Consistent revenue stream of $1.1 billion to $1.3 billion from 290,000 customers...
Strategic use of Energy Transition Bonds to fund grid modernization and renewabl...

Read Analysis

🤖 AI Generated

Thayer Ventures Acquisition Corp II

10-K March 30, 2026

Key Highlights

Raised $201.25 million in IPO to target travel, transportation, and hospitality ...
Experienced leadership team with over 50 years of combined industry expertise.
Capital is held in a secure U.S. trust account, providing downside protection fo...

Read Analysis

🤖 AI Generated

Spark I Acquisition Corp

10-K March 30, 2026

Key Highlights

Active negotiations underway for a merger with Kneron Holding Corporation, a lea...
Trust account holds $100.5 million in cash, providing a stable floor for investo...
Shareholder approval secured for a merger deadline extension until September 29,...

Read Analysis

🤖 AI Generated

Neumora Therapeutics, Inc.

10-K March 30, 2026

Key Highlights

High-stakes Phase 3 data for Navacaprant expected in Q2 2026.
Strong cash position of $450 million provides runway into late 2027.
Pipeline diversification with upcoming schizophrenia data in late 2026.

Read Analysis

🤖 AI Generated

Brightwood Capital Corp I

10-K March 30, 2026

Key Highlights

Focuses on first lien senior secured loans, ensuring priority repayment in the e...
Targets high-yield middle-market lending with typical interest rates between 8% ...
Operates as a BDC, providing active managerial assistance to portfolio companies...

Read Analysis

🤖 AI Generated

Lexeo Therapeutics, Inc.

10-K March 30, 2026

Key Highlights

Lead gene therapy candidate LX2006 demonstrated safety and a 25% reduction in he...
Technology platform leverages research from Weill Cornell Medicine to target roo...
Company is successfully progressing toward a final, large-scale clinical study f...

Read Analysis

🤖 AI Generated

Electra Battery Materials Corp

20-F March 30, 2026

Key Highlights

Developing North America's first refinery for battery-grade cobalt sulfate.
Strategic debt-to-equity conversion removed $30M–$40M in debt obligations.
Secured over $20M in government grants and loans to support infrastructure.

Read Analysis

🤖 AI Generated

VOX ROYALTY CORP.

40-F March 30, 2026

Key Highlights

Achieved record revenue of $18.4 million, a 22% year-over-year increase.
Acquired a $57.5 million 'Global Gold Portfolio' to expand royalty assets.
Initiated a quarterly dividend of $0.015 per share, offering a 2.1% yield.

Read Analysis

🤖 AI Generated

Stay Informed with AI Analysis

Get comprehensive insights from annual reports with our AI-powered analysis. Track corporate performance, financial trends, and strategic developments.

Back to Homepage